Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-06 Purchase | 2022-01-10 8:37 pm | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 3,947 | $19 | $74,993 | 12,347 (Direct) | View |
| 2021-08-10 Purchase | 2021-08-11 4:09 pm | COVETRUS INC. | CVET | FONTEYNE PAUL R. Director | 5,000 | $23.24 | $116,200 | 5,000 (Direct) | View |
| 2020-05-08 Purchase | 2020-05-12 5:53 pm | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 5,000 | $31.81 | $159,034 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-07 4:52 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-02 4:13 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 5,748 | $59.86 | 22,186 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-02 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 3,341 | $0 | 22,186 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 7:34 pm | N/A 2033-06-08 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 16,985 | $0 | 16,985 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 5:31 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 11,308 | $0 | 20,538 (Direct) | View |
| 2022-10-13 Disposition | 2022-10-13 11:03 am | N/A N/A | COVETRUS INC. | CVET | FONTEYNE PAUL R. Director | 27,913 | $0 | 0 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-06 4:06 pm | N/A 2022-07-01 | COVETRUS INC. | CVET | FONTEYNE PAUL R. Director | 8,275 | $0 | 13,275 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:05 pm | N/A 2032-06-09 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-13 4:10 pm | N/A N/A | COVETRUS INC. | CVET | FONTEYNE PAUL R. Director | 14,638 | $0 | 14,638 (Direct) | View |
| 2022-05-06 Option Award | 2022-05-09 4:17 pm | N/A N/A | GELESIS HOLDINGS INC. | GLS | FONTEYNE PAUL R. Director | 53,832 | $0 | 53,832 (Direct) | View |
Ownership | 2022-01-24 4:39 pm | N/A 2027-01-13 | GELESIS HOLDINGS INC. | GLS | FONTEYNE PAUL R. Director | 0 | $0 | 292,687 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 8:37 pm | N/A 2032-01-06 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 8,400 | $0 | 12,347 (Direct) | View |
Ownership | 2022-01-06 5:06 pm | N/A 2031-03-23 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 0 | $0 | 81,100 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 9:28 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 12,784 | $0 | 17,784 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 4:03 pm | N/A 2022-07-01 | COVETRUS INC. | CVET | FONTEYNE PAUL R. Director | 8,275 | $0 | 8,275 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 7:31 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 27,600 | $0 | 27,600 (Direct) | View |
| 2020-11-16 Disposition | 2020-11-17 3:40 pm | N/A N/A | AMAG PHARMACEUTICALS INC. | AMAG | FONTEYNE PAUL R. Director | 51,417 | $0 | 0 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 4:32 pm | N/A 2030-06-02 | resTORbio Inc. | TORC | FONTEYNE PAUL R. Director | 14,414 | $0 | 14,414 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-04 4:49 pm | N/A 2030-06-02 | AMAG PHARMACEUTICALS INC. | AMAG | FONTEYNE PAUL R. Director | 31,558 | $0 | 35,965 (Direct) | View |
| 2020-04-02 Option Award | 2020-04-06 5:37 pm | N/A 2030-04-01 | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 37,500 | $0 | 37,500 (Direct) | View |